Please login to the form below

Not currently logged in
Email:
Password:

Mereo BioPharma appoints CFO

Richard Jones joins the rare diseases specialist

London, UK-based Mereo BioPharma Group has appointed Richard Jones as chief financial officer and member of the board of directors, effective from early 2017.

Jones joins the rare and specialty diseases clinical-stage company from Shield Therapeutics, where he most recently served as chief financial officer and company secretary.

Prior to this, Jones worked in investment banking and specialised in advising healthcare clients. He held a number of senior positions as Brewin Dolphin Securities, Investec and PricewaterhouseCoopers.

Dr Denise Scots-Knight, chief executive of Mereo BioPharma, said: “I am delighted to announce the appointment of Richard Jones as our chief financial officer and to the board of directors.

“His extensive financial experience in healthcare industry, initially as an investment banker in the sector and more recently as chief financial officer of Shield Therapeutic, complements that of the other members of Mereo's executive team.

“Following our positive debut as a listed company, the board is confident that Richard will make a valuable and significant contribution to Mereo's future success.”

21st November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics